为牙髓用途开发的表没食子儿茶素-3-没食子酸酯制剂:理化与生物学评价
本研究开发基于绿茶来源EGCG的牙髓内封药制剂,评估其理化特性与生物学性能。EGCG在酸性pH及1-27小时内理化性质稳定;小鼠皮下组织相容性良好,各浓度未见明显不良反应;犬牙实验性根尖周病变经EGCG制剂处理后根尖周透射区缩小并实现组织修复。
要点
- EGCG制剂在酸性pH及1-27小时内保持理化稳定,波长维持274 nm
- 1.25-20 mg/mL浓度小鼠皮下组织相容性良好,无显著不良反应
- 犬牙模型中EGCG制剂促进根尖周病变修复,与对照无显著差异
核心结论
- 基于绿茶EGCG开发的牙髓内封药制剂具有理化稳定性和组织相容性,并能促进根尖周病变修复。
研究设计与样本
- 先以紫外-可见和荧光光谱对EGCG进行理化表征,评估酸性pH及1-6、24、27小时下的性质保持。
- 生物学研究评估1.25、5、10、20 mg/mL的EGCG制剂:小鼠皮下组织相容性(24小时血浆渗漏及7、21、63天宏观与微观检查)。
- 同时评估犬牙实验性根尖周病变的放射学与组织病理学修复,统计采用卡方检验、Fisher精确检验、方差分析及Tukey事后检验,显著性水平5%。
主要发现
- 紫外-可见分光光度法显示EGCG在酸性pH及时间作用下性质未改变,波长保持274 nm。
- 7、21、63天宏观参数显示各浓度EGCG组无上皮溃疡或仅轻度浅表组织坏死、水肿或血管化,与对照组无显著差异。
- 各期微观检查所有组均无脓肿灶和水肿,可见纤维包囊和新生血管,除氢氧化钙糊剂组外均见修复组织伴轻度中性粒细胞浸润。
- 氢氧化钙糊剂组在第7和21天炎症和组织坏死更明显(P < .001),第63天所有组炎症浸润和坏死均消失。
- 犬牙评估显示EGCG制剂治疗减少根尖周透射区并实现根尖及根尖周组织修复(P > .05)。
关键数值与推荐
- EGCG理化性质在酸性pH及1-6、24、27小时内保持稳定,波长274 nm。
- EGCG制剂浓度设为1.25、5、10、20 mg/mL用于生物学评价。
- 氢氧化钙糊剂组在第7和21天炎症与组织坏死较EGCG组更明显(P < .001)。
- 犬牙根尖周病变修复评估中EGCG组与对照比较P > .05。
临床怎么用
- EGCG制剂可作为牙髓内封药的候选方案,具有组织相容性且可能促进根尖周病变修复。
- 与氢氧化钙糊剂相比,EGCG制剂在早期(7-21天)组织反应更轻,但需进一步临床验证。
局限性
- 研究为动物实验(小鼠皮下及犬牙模型),尚未在人体中验证。
- 样本量、具体统计学数值及长期疗效未在摘要中完整报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Although epigallocatechin-3-gallate (EGCG) from green tea has been successfully used in the prevention and treatment of several infectious and immunoinflammatory diseases because of its proven anti-inflammatory, antioxidant, antimicrobial, and antiresorptive role, its use as an intracanal dressing has not been proposed. The aim of this study was to develop a formulation based on EGCG for endodontic use by assessing its physicochemical and biological properties. METHODS: Initially, physicochemical characterization of EGCG was performed by ultraviolet-visible and fluorescence spectroscopy to evaluate if the properties were maintained in acidic pH and time (1-6, 24, and 27 hours). After that, biological studies evaluated the developed formulation of EGCG at different concentrations (1.25, 5, 10, and 20 mg/mL). The tissue compatibility with subcutaneous tissue of mice was evaluated by plasma leakage after 24 hours and the examination of macroscopic and microscopic features at 7, 21, and 63 days after the insertion of polyethylene tubes containing the formulations. The repair of experimentally induced periapical lesions in dog's teeth by radiographic and histopathologic analysis was also evaluated. The scores were statistically analyzed by the chi-square and Fisher exact test. Analysis of variance followed by the Tukey posttest were used for the quantitative analysis. The significance level was 5%. RESULTS: The physicochemical characterization performed under ultraviolet-visible spectrophotometry showed that the EGCG properties remained unaltered in acid pH and function of time, keeping its wavelength to 274 nm. Macroscopic parameters evaluated at 7, 21, and 63 days showed that all concentrations presented no epithelial ulceration or presence of mild superficial tissue necrosis, edema, or vascularization with no significant difference in the control group. During all periods of microscopic examination, all groups presented the absence of abscess foci and edema and the presence of fibrous capsule and neovascularization. The presence of reparative tissue with a gentle presence of neutrophilic inflammatory cells was also observed for all groups, except for the calcium hydroxide paste group, which presented a more pronounced inflammation and tissue necrosis at days 7 and 21 (P < .001). At day 63, all groups presented an absence of inflammatory infiltrate and necrosis. The evaluation of dog teeth showed that treatment with the EGCG formulation provided a reduction of the periapical radiolucent area and allowed the repair of apical and periapical tissues (P > .05). CONCLUSIONS: The developed formulation based on EGCG from green tea presented physicochemical stability and tissue compatibility and provided the repair of periapical lesions when used as an intracanal dressing.
引用
- De Rossi A, Araújo Ferreira DC, Liévana FS, et al. An Epigallocatechin-3-gallate Formulation Developed for Endodontic Use: A Physicochemical and Biological Evaluation. J Endod. 2021. PMID: 34157344. doi:10.1016/j.joen.2021.06.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。